Onderzoeker
Paul Declerck
- Disciplines:Laboratoriumgeneeskunde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen, Medische biotechnologie, Ontdekking en evaluatie van geneesmiddelen, Farmaceutica
Affiliaties
- Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf1 apr 2013 → 30 sep 2023
Publicaties
1 - 10 van 197
- Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies(2023)
Auteurs: Paul Declerck
- DEVELOPMENT OF ANTI-TAU INTRABODIES TO TARGET TAU PATHOLOGY IN ALZHEIMER’S DISEASE(2023)
Auteurs: Dina Rodrigues Martins, Paul Declerck
- FLUIDOT: A case study on drug tolerance screening and antibody mining, one cell at a time(2023)
Auteurs: Karen Ven, Jolien Breukers, Iene Rutten, Maya Imbrechts, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, et al.
- Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice(2023)
Auteurs: Marie-Lynn Cuypers, Nick Geukens, Paul Declerck, Maarten Dewilde
- Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn's Disease(2023)
Auteurs: Bram Verstockt, Séverine Vermeire, Debby Thomas, Paul Declerck
Pagina's: 838 - + - FLUIDOT: a Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining(2023)
Auteurs: Jolien Breukers, Karen Ven, Iene Rutten, Maya Imbrechts, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease(2023)
Auteurs: Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, Séverine Vermeire, Paul Declerck, Debby Thomas
- Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model(2022)
Auteurs: Debby Thomas, Maarten Dewilde, Nick Geukens, Paul Declerck
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Auteurs: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking(2022)
Auteurs: Liese Barbier, Steven Simoens, Paul Declerck, Arnold Vulto, Isabelle Huys
Patenten
1 - 1 van 1
- Dual targeting of tafi and pai-1 (Inventor)